NovMetaPharma Market Cap

NovMetaPharma has a market cap or net worth of 114.03 billion as of March 13, 2026. Its market cap has increased by 87.06% in one year.

Market Cap

114.03B

Enterprise Value

n/a

Revenue

1.30B

Ranking

n/a

PE Ratio

74.00

Stock Price

8,880.00

Market Cap Chart

Since April 5, 2017, NovMetaPharma's market cap has increased from 74.59B to 114.03B, an increase of 52.88%. That is a compound annual growth rate of 4.86%.

Market Cap History

Date	Market Cap	% Change
Mar 12, 2026	114.03B	-30.34%
Dec 30, 2025	163.69B	187.16%
Dec 30, 2024	57.00B	-46.33%
Dec 29, 2022	106.21B	-45.89%
Dec 30, 2021	196.29B	-9.50%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
IMGT Co.,Ltd.	122.47B
BIO-FD&C	122.17B
CORESTEMCHEMON	117.55B
ViGenCell	117.46B
Progen	102.24B
Quratis	99.21B
TegoScience	96.08B
CTCBIO	95.75B

Market Cap Rankings